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Abstract 
Aim 
Evidence from meta-analyses of randomised clinical trials show interventions for young 
people at ultra high risk (UHR) of developing psychosis are effective both clinically and 
economically. While research evidence has begun to be integrated into clinical guidelines, 
there is a lack of research on the implementation of these guidelines. This paper examines 
service provision for UHR individuals in accordance with current clinical guidelines within 
the National Health Service (NHS) in England. 
Method 
A self-report online survey was completed by clinical leaders of Early Intervention in 
Psychosis (EIP) teams (N=50) within the NHS across the UK. 
Results 
Of the 50 EIP teams responding (from 30 NHS Trusts), 53% reported inclusion of the UHR 
group in their service mandate, with age range predominantly 14-35 years (81%) and service 
provided for at least 12 months (53%). Provision of services according to NICE clinical 
guidelines showed 50% of services offered cognitive behavioural therapy (CBT) for 
psychosis, and 42% offered family intervention. Contrary to guidelines, 50% of services 
offered antipsychotic medication. Around half of services provided training in assessment by 
CAARMS, psycho-education, CBT for psychosis, family work and treatment for anxiety and 
depression. 
Cconclusions 
Despite clear evidence for the benefit of early intervention in this population, current 
provision for UHR within EIP services in England does not match clinical guidelines. While 
some argue this is due to a lack of allocated funding, it is important to note the similar 
variable adherence to clinical guidelines in the treatment of people with established 
schizophrenia. 
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Service provision for ultra-high risk for psychosis: A survey of early intervention 
in psychosis services in England 
Introduction 
It is well established that the majority of mental health disorders begin before 
adulthood and persist across the lifespan (1). Surveys in the United Kingdom estimate the 
incidence of psychosis at five per 1000 adults (2), with the diagnosis of schizophrenia 
accounting for around 30% of adult mental health and social care monetary budgets (3). 
Schizophrenia disrupts social and family relationships, resulting in severe educational and 
occupational impairment, lost productivity, unemployment, physical illness, and premature 
mortality (4). 
The onset of psychosis is invariably preceded by early symptom development 
characterised by a range of non-specific behavioural and psychological symptoms, as well as 
functional deterioration, and has been conceptualised as an ultra-high risk (UHR) mental state 
(5). Yung et al. (1998) developed criteria proposed to predict the onset of a psychotic 
disorder, specifically: low intensity/frequency psychotic symptoms, brief limited psychotic 
symptoms and/or genetic risk in the presence of functional decline (6). Among people 
identified as UHR for psychosis, around 22% transition to a psychotic disorder within 12 
months and 36% after three years (7-9). Long term follow up studies have shown ongoing 
mental health problems for UHR individuals who have not transitioned to psychosis (10, 11). 
A six year follow up of UHR individuals who had not transitioned found 28.3% reported 
attenuated psychotic symptoms and for 61.5% of those with comorbid disorders at baseline 
these comorbidities were still present (12). 
Interventions that delay or prevent transition to psychosis are considered valuable at 
both economic and individual levels (13, 14). A recent meta-analysis of psychological, 
pharmacological or nutritional interventions to prevent or delay transition to psychotic 
disorders for UHR individuals found cognitive behavioural therapy effective in reducing 
transition to psychosis at 12 months (risk ratio 0.54, 95% confidence interval 0.34 to 0.86). 
The meta-analysis also showed that omega-3 fatty acids and integrated psychotherapy 
interventions were associated with reductions in transition to psychosis at 12 months (15). 
However, limitations regarding evidence quality were highlighted. The results of five trials 
examining CBT within a meta-analysis of interventions for UHR for psychosis, found the 
number needed to treat (NNT) for one person to avoid transition to psychosis was 11 (13). A 
further meta-analysis of only CBT interventions for prevention of psychosis identified six 
randomised trials (16). The results of this meta-analysis indicated that CBT interventions 
were associated with a reduced rate of transition to psychosis at six, 12 and 18–24 months 
after treatment, in comparison to monitoring or non-specific supportive therapy.   
Clinical guidelines for psychosis have been derived from research evidence to provide 
recommendations to clinicians for best practice. For established schizophrenia, one 
systematic review identified and compared 24 guidelines from 18 countries (17). The review 
showed that the recommendations for pharmacotherapy were similar internationally, but that 
there was great variability in the guidelines for psycho-social interventions for people with 
schizophrenia. 
Recommendations for the treatment of UHR individuals have also been developed 
from research evidence. For example, the International Early Psychosis Association (IEPA) 
recommended: 1) regular monitoring; 2) interventions aimed at specific difficulties (i.e. 
anxiety, depression, substance misuse); 3) help with interpersonal, vocational and family 
stress; 4) support to develop coping skills for sub-threshold symptoms and; 5) 
individual/family psycho-education (18). The IEPA recommends that these interventions are 
provided flexibly and in low stigmatising environments (i.e. home, primary care or youth-
based settings). Clinical Practice Guidelines have been developed in the United Kingdom (19, 
20), Australia (18) and Canada (21) (see Table 1). 
[INSERT TABLE 1 AROUND HERE] 
Based on evidence from naturalistic cohort studies (e.g., (22, 23), NICE (2013) 
acknowledges that current clinical practice is likely to be highly variable, due to local 
resources and service configurations, clinician attitudes and awareness of clinical guidelines 
(19). For example, recent estimates for the implementation of CBT and Family Intervention 
(FI) as per NICE guidance for schizophrenia reported rates of implementation of 5.3% for 
CBT and 1.1% for FI (24). Further challenges to the implementation of guidelines were 
highlighted in an audit investigating early intervention in psychosis service development, 
whereby there exists inconsistencies between service models, resources and delivery such as 
age of clients accepted to the service and the length of care provided (25). 
While the research evidence for interventions for UHR individuals is growing and has 
begun to be integrated into a range of clinical guidelines across countries, there is a lack of 
research on the implementation of clinical guidelines for this population. Therefore, the aim 
of this paper is to examine service provision for UHR individuals in accordance with current 
clinical guidelines (e.g., NICE) and within the National Health Service (NHS) in England. 
 
Method 
A survey of early intervention for psychosis (EIP) teams within the NHS across 
England was conducted using a self-report online survey. Only dedicated EIP services were 
recruited and thus the sample did not include generic early intervention services in the 
community. The survey was developed based on current clinical guidelines in UK, Australia 
and Canada, and included the following domains: service provision for UHR (such as service 
inclusion criteria, duration of inclusion), screening, assessment and interventions for UHR, 
and training provision for staff working with UHR individuals within EIP teams. The survey 
comprised multiple choice and free form questions and was piloted with three clinicians 
(Nurse, Psychologist, Psychiatrist) working in EIP teams. Feedback was provided and 
incorporated to ensure clarity of understanding and interpretation. Early intervention teams 
were identified through the Initiative to Reduce the Impact of Schizophrenia (IRIS) Network 
(26). The network is drawn from the key national leads, regional leads and EIP practitioners 
working in services. The network identified EIP team leaders in the NHS in England who 
were then sent an email with a link to the online survey (Bristol Online Survey). A snowball 
method was employed, whereby service leaders were asked to forward the survey to leaders 
of other EIP services in order to achieve a comprehensive coverage. The survey controlled 
for multiple entries from services by asking participants to name their service. Data were 
collected between April and August 2014. At the time of data collection there were 150 EIP 
services in England. Analysis was undertaken using IBM Statistical Package for the Social 
Sciences version 20 for Windows to provide descriptive statistics of the data-set. 
Results 
Fifty EIP service teams covering 30 National Health Service Trusts in England 
responded to the survey. Fifty three percent of these services reported including provision of 
services for UHR for psychosis. The following data are drawn from this subset of the main 
sample, namely, services that provided for UHR individuals. See Table 2 for descriptive data. 
Inclusion and assessment 
The majority of EIP services that reported including UHR individuals, provided 12 
months or more of service for UHR (65%). Predominantly EIP services included UHR 
individuals between the ages of 14-35 years (81%) and meeting criteria using an assessment 
tool such as the Structured Interview for Prodromal Symptoms / Scale of Prodromal 
Symptoms (SIPS/SOPS) (9), or Comprehensive Assessment of At Risk Mental States 
(CAARMS) (69%). For services that included a screen for UHR, there was much variability 
in the tools employed, with the CAARMS and the Prodromal Questionnaire (27) more 
prevalent, 15% and 11% respectively. The assessment of UHR individuals was principally 
conducted utilising the CAARMS or SIPS/SOPS (50%). 
[INSERT TABLE 2 AROUND HERE] 
 
Intervention 
Interventions predominantly employed by EIP services for UHR individuals were psycho-
education (96%), monitoring of mental state / “watchful waiting” (88%), treatment for 
anxiety (77%), cognitive behavioural informed interventions (73%), and family work (61%). 
The recommended NICE standard interventions, namely, CBT for psychosis and family 
intervention were reported as provided by 50% and 42% of services respectively. 
Antipsychotic medication was utilised by 50% of services and 4% of services offered 
Omega-3 fatty acids/fish oils as a treatment. Comorbidity was addressed by 23-58% of 
services. 
[INSERT TABLE 3 AROUND HERE] 
 
Training 
Training of staff on UHR status core assessment instruments such as CAARMS and 
SIPS/SOPS was provided by 46% and 11% of EIP services respectively. The most common 
staff training for interventions focussed on psycho-education (64% of services). Many 
services provided training on interventions for comorbidity such as anxiety (58%), depression 
(46%) and substance misuse (38%). Training for the NICE recommended interventions of 
CBT for psychosis and family therapy were provided by 46% and 34% of services 
respectively. 
Discussion 
Research shows that young people who are at UHR for psychosis can be reliably detected 
[27, 28] and classified [29], with treatment such as cognitive behavioural intervention 
directed at normalising the subclinical symptoms, unusual experiences, salience and 
perceptual aberrations demonstrating efficacy for preventing the number of transitions to 
psychotic disorder by about half (13, 28). However, early intervention in psychosis services 
remain predominantly focussed on intervention for first episode psychosis (FEP) rather than 
prevention of psychotic disorder by intervening in the prodromal stage, namely the UHR for 
psychosis group. As evidenced by our data just over half of EIP services reported inclusion of 
the UHR group in their service mandate. These findings contrast with robust research 
evidence demonstrating the effectiveness of early intervention in the UHR group (13, 15, 16) 
and the subsequent cost savings for the health services (14). When services include UHR 
individuals, there appears to be a general consensus about the target population. For example, 
the majority of EIP services set inclusion criteria for 14-35 year olds and provided service for 
a period of 12 months or more. 
Concordance with clinical guidelines for intervention in UHR for psychosis showed only half 
of services provided CBT for psychosis and less than half (42%) provided family 
intervention. NICE standard CBT is the recommended first line of treatment for the UHR 
population and yet less than 50% of services are providing training on CBT. Therefore, it is 
not surprising that less than half of services are providing this first line treatment. Despite the 
body of evidence for the efficacy and cost effectiveness of CBT (13, 14) in the UHR 
population, our data indicate that resources are not being allocated for the training of EIP 
teams. 
The majority of services provided non psychosis specific interventions targeting comorbidity 
or adopting a wait and see approach. The NICE guidelines recommend monitoring of 
symptoms but this should not be in the absence of active psychotherapies such as CBT. 
Monitoring of mental state was conducted by 88% of services and 64% provided psycho-
education, with both approaches essential for the UHR individual in gaining understanding 
and management of their mental health problems. Our data did not allow an examination of 
whether monitoring was used in the absence of other interventions. Treatment for 
comorbidity such as anxiety, depression and substance use was provided by three quarters of 
the services. 
NICE guidelines recommend that antipsychotic medication should not routinely be used with 
UHR individuals. In addition, the Australian and New Zealand Early Intervention clinical 
guidelines, advocate that antipsychotic medication should not be utilised unless (i) at least 
one week of frank positive psychotic symptoms has been sustained; or (ii) a rapid worsening 
of psychotic symptoms accompanied by significant functional decline and elevated risk to 
self or others (15). In the current study antipsychotic medication was an intervention provided 
for UHR in at least half of the services. One plausible interpretation is that a lack of follow up 
on assessments may lead to a lack of clarity in respect to diagnostic status such that some of 
these people may have transitioned to psychosis or that prescribing is for other reasons such 
as bipolar disorder or sleep disturbance. Alternatively, this finding may reflect a more 
fundamental problem, namely that recommended guidelines are not being implemented as 
evidenced in the treatment of people with schizophrenia (3, 24). 
 
The rates of training provision for staff were relatively consistent with the proportion of 
services delivering specific assessments (CAARMS, SIP/SOPS) and interventions (CBT for 
psychosis, NICE family therapy). Around half of services provided training in assessment by 
CAARMS, psycho-education, NICE CBT for psychosis, general family work and treatment 
for anxiety and depression. Interestingly, while 88% of services adopted a monitoring of 
mental state approach, only 34% reported receiving training for this. 
Strengths and limitations 
Few studies have examined the degree of inclusion of UHR populations within public mental 
health services. Most studies have focused on specialist UHR services such as Headspace 
(29) and Headstrong (30). Our study sampled 54% of NHS Trusts (i.e., public mental health 
services) across England and thus represents a wide geographical spread. A strength of the 
current study is that it provides a broad overview regarding the implementation of 
recommended guidelines across England. However, this broad focus on service level alone, 
means that it is unclear at the individual patient level how guidelines are being implemented 
such as what combination of interventions are provided and within what time frame. Future 
studies would benefit from undertaking a more in-depth examination of staff training. Given 
that staff skills are fundamental to the implementation, there is a need to delineate current 
barriers, such as staff knowledge of guidelines, the quality of training provision and the 
availability of training for staff within teams. 
The majority of EIP services in England do not receive allocated funding for the UHR 
population and there are few stand alone services specifically commissioned for the UHR 
population nationally. For most services, the UHR service is provided as an adjunct to the 
FEP service. The UHR population would not have been included in the original 
commissioning or funding of services as this occurred prior to the release of NICE guidance 
for this clinical population. Thus, for many services the provision of a UHR service is 
contingent on capacity within the FEP service. UHR was included in the UK clinical 
guidelines for psychosis and schizophrenia for the first time in 2013. A new Access & 
Waiting Time target was introduced nationally in the UK from April 2016 in which providers 
will be mandated to complete an assessment within two weeks of referral for both FEP and 
UHR individuals, followed by a NICE concordant care package for first episode psychosis. A 
national investment in funding will support this initiative to increase the availability of UHR 
interventions across the UK, thus it will be important to continue to monitor the 
implementation of guidelines as changes are implemented. 
 
Conclusions 
The results of this study are very timely given the proposed introduction in 2016 of a national 
directive for UK services to provide NICE concordant care for people at UHR for psychosis 
(NHS England, 2016). Our findings show limited provision of NICE recommended treatment 
for UHR for psychosis and that in relation to use of antipsychotic medication some services 
are providing interventions contrary to guidelines. While the lack of adherence to guidelines 
may be due in part to lack of dedicated funding and staff training, it mirrors the poor 
concordance of clinical guidelines in the treatment of schizophrenia (24, 25). It is of concern 
that a national UK directive is proposed for concordance with UHR clinical guidelines when 
our study (i) is the first to examine rates of concordance and (ii) shows a lack of staff training 
and resources. 
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Table 1: Clinical guidelines for the treatment of UHR for psychosis 
Recommendation United Kingdom 
(NICE) 
Canada 
(CPA) 
Australia &NZ 
(RANZCP) 
Early assessment and 
monitoring of symptoms 
   
Individual CBT for psychotic 
symptoms 
   
Treatment for co-morbid 
mental health problems (eg 
anxiety, depression) 
   
Supportive therapy    
Omega -3 fatty acids    
Family therapy    
Antipsychotic medication 
should not be used as a first 
treatment option 
   
 
  
Table 2: Services provided for UHR in EIP services 
Service Provision for UHR EIP services 
% (N) 
Duration of service provision 
3-6 months 
12 months 
> 12 months 
 
34 (9) 
19 (5) 
46 (12) 
Criteria for UHR inclusion 
Age (years) 
14-35 
14-65 
16-25 
16-35 
18-35 
Clinical status (SIPS/SOPS, CAARMS) 
Not meeting criteria for PANNS 
 
 
81 (21) 
4 (1) 
8(2) 
4 (1) 
4 (1) 
69 (18) 
27 (7) 
Directorate for UHR service 
Child and Adolescent Services 
Adult Services 
Both 
Not known 
 
19 (5) 
69 (18) 
4 (1) 
8(2) 
Assertive Engagement  
Yes 
No 
 
77 (20) 
23 (6) 
Assessment and Screening for UHR 
Screening Employed (yes) 
Screening Instrument 
CAARMS 
SIPS/SOPS 
Prodromal Questionnaire 
Psychosis Checklist 
SCID-II 
SPI-A 
Comprehensive Core Assessment 
Pre morbid adjustment Scale 
 
Assessment Instrument 
CAARMS 
SIPS/SOPS 
PANNS 
Combination of the above  
 
50 (13) 
 
15 (4) 
8 (2) 
11 (3) 
4 (1) 
4 (1) 
4 (1) 
4 (1) 
4 (1) 
 
 
31 (8) 
19 (5) 
11 (3) 
23 (7) 
Intervention for UHR 
Psycho-education 
NICE standard CBT for psychosis 
Cognitive Behavioural informed interventions 
NICE standard family therapy 
Family work 
Group work 
Omega-3 fatty acids /fish oils 
Monitoring of mental state/ watchful waiting 
Antipsychotic medication 
Comorbid Disorders 
 
96 (25) 
50(13) 
73 (19) 
42 (11) 
61 (16) 
42 (11) 
4 (1) 
88 (23) 
50 (13) 
73(19) 
Training for staff 
Assessments 
CAARMS 
PANNS 
SIPS/SOPS 
KGV psychosis scale 
Modelling/ Observation 
SPI-A 
Intervention  
Psycho-education 
NICE standard CBT for psychosis 
Cognitive Behavioural informed interventions 
NICE standard family therapy 
Family work 
Group work 
Omega-3 fatty acids /fish oils 
Monitoring of mental state/ watchful waiting 
Antipsychotic medication 
Comorbid Disorders 
 
 
 
46(12) 
19 (5) 
11 (3) 
8 (2) 
8 (2) 
4 (1) 
 
64 (17) 
46 (12) 
42 (11) 
34 (9) 
46 (12) 
19 (5) 
- 
34 (9) 
31 (8) 
61(16) 
 
  
Table 3: Service delivery and training compared to UK clinical guidelines (NICE) 
 
NICE 
Guideline 
Percentage of EIP services 
United Kingdom Service delivered Training 
delivered 
Early assessment and 
monitoring of symptoms 
 88% (monitoring) 34-46% 
Individual CBT for psychotic 
symptoms 
 50% 46% 
Treatment for co-morbid 
mental health problems (eg 
anxiety, depression) 
 31-77% 23-58% 
Family intervention  42% 34% 
Antipsychotic medication 
should not be used as a first 
treatment option 
 50% 31% 
 
 
